A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cells

Oncogene

Volumn 25, Issue 19, 2006, Pages 2773-2784

  Wojcik, E J ^a   Sharifpoor, S ^a   Miller, N A ^a   Wright, T G ^a   Watering, R ^a   Tremblay, E A ^a   Swan, K ^a   Mueller, C R ^a   Elliott, B E ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Breast carcinoma cells; HGF expression; Src; Stat3

Indexed keywords

MESSENGER RNA; PROTEIN KINASE P60; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CANCER INVASION; CARCINOMA CELL; CELL TRANSFORMATION; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC CONSERVATION; HGF GENE; HUMAN; MOUSE; NONHUMAN; ONCOGENE SRC; ONCOGENE STAT3; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTO ONCOGENE; STROMA CELL; TRANSCRIPTION INITIATION;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HEPATOCYTE GROWTH FACTOR; LUCIFERASES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MUTATION; PROTO-ONCOGENE PROTEINS PP60(C-SRC); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

ANIMALIA;

EID: 33646557679     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209306     Document Type: Article

References (50)

1. Andermarcher E, Surani MA, Gherardi E. (1996). Dev Genet 18: 254-266.
2. Atlas E, Stramwasser M, Whiskin K, Mueller CR. (2000). Oncogene 19: 1933-1940.
3. Ball RK, Friis RR, Schoenenberger CA, Doppler W, Groner B. (1988). EMBO J 7: 2089-2095.
4. Bell AW, Jiang JG, Chen Q, Liu Y, Zarnegar R. (1998). J Biol Chem 273: 6900-6908.
5. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C. (1995). Nature 376: 768-771.
6. Boccaccio C, Ando M, Tamagnome L, Bardelli A, Michieli P, Battistini C et al. (1998). Nature 391: 285-288.
7. Braunstein J, Brutsaert S, Olson R, Schindler C. (2003). J Biol Chem 278: 34133-34140.
8. Bussolino F, Di Renzo MF, Ziehe M, Bocchietto E, Olivero M, Naldini L et al. (1992). J Cell Biol 119: 629-641.
9. Byers S, Park M, Sommers C, Seslar S. (1994). Breast Cancer Res Treat 31: 203-215.
10. Darnell Jr JE. (2002). Nat Rev Cancer 2: 740-749.
11. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S et al. (1992). Oncogene 7: 2549-2553.
12. Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L et al. (1995a). Clin Cancer Res 1: 147-154.
13. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P et al. (1994). Int J Cancer 58: 658-662.
14. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR. (1995b). Cancer Res 55: 1129-1138.
15. Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. (2003). Clin Cancer Res 9: 594-600.
16. Elliott BE, Hung WL, Boag AH, Tuck AB. (2002). Can J Physiol Pharmacol 80: 91-102.
17. Gallego MI, Bierie B, Hennighausen L. (2003). Oncogene 22: 8498-8508.
18. Horvath CM, Wen Z, Damell JEJ. (1995). Genes Dev 9: 984-994.
19. Hung W, Elliott B. (2001). J Biol Chem 276: 12395-12403.
20. Jiang JG, DeFrances MC, Machen J, Johnson C, Zarnegar R. (2000a). Biochem Biophys Res Commun 272: 882-886.
21. Jiang JG, Gao B, Zarnegar R. (2000b). Oncogene 19: 2786-2790.
22. Jiang JG, Johnson C, Zarnegar R. (2001). J Biol Chem 276: 25049-25056.
23. Jiang J-G, Zarnegar R. (1997). Mol Cell Biol 17: 5758-5770.
24. Jin L, Fuchs A, Schnitt SJ, Yao Y, Joseph A, Lamszus K et al. (1996). Cancer 79: 749-760.
25. Klosek SK, Nakashiro K, Hara S, Li C, Shintani S, Hamakawa H. (2004). Oncol Rep 12: 293-296.
26. Liu Y, Beedle AB, Lin L, Bell AW, Zarnegar R. (1994a). Mol Cell Biol 14: 7046-7058.
27. Liu Y, Michalopoulos GK, Zarnegar R. (1994b). J Biol Chem 269: 4152-4160.
28. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS, Sukhatme VP. (1995). Nature 375: 577-581.
29. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J et al. (2002). Oncogene 21: 2000-2008.
30. Olivero M, Rizzo M, Madeddu R, Casadio C, Pennacchietti S, Nicotra MR et al. (1996). Br J Cancer 74: 1862-1868.
31. Paz K, Socci ND, van Nimwegen E, Viale A, Darnell JE. (2004). Oncogene 23: 8455-8463.
32. Plaschke-Schlutter A, Behrens J, Gherardi E, Birchmeier W. (1995). J Biol Chem 270: 830-836.
33. Rahimi N, Hung W, Saulnier R, Tremblay E, Elliott B. (1998). J Biol Chem 273: 33714-33721.
34. Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B. (1996). Cell Growth Differ 7: 263-270.
35. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M et al. (1995). Nature 373: 699-702.
36. Seidel HM, Milocco LH, Lamb P, Darnell JEJ, Stein RB, Rosen J. (1995). Proc Natl Acad Sci USA 92: 3041-3045.
37. Siegfried JM, Weissfeld LA, Singh-Kaw P, Weyant RJ, Testa JR, Landreneau RJ. (1997). Cancer Res 57: 433-439.
38. Tomida M, Saito T. (2004). Oncogene 23: 679-686.
39. Trovato M, Vitarelli E, Grosso M, Alesci S, Benvenga S, Trimarchi F et al. (2004). Eur J Histochem 48: 291-297.
40. Tuck AB, Park M, Sterns EE, Boag A, Elliott BE. (1996). Am J Path 148: 225-232.
41. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M et al. (1999). Mol Cell Biol 19: 7519-7528.
42. Turkson J, Bowman T, Garcia R, Caldenhoven E, De Groot RP, Jove R. (1998). Mol Cell Biol 18: 2545-2552.
43. Vultur A, Cao J, Arulanandam R, Turkson J, Jove R, Greer P et al. (2004). Oncogene 23: 2600-2616.
44. Wang Y, Selden AC, Morgan N, Stamp GW, Hodgson HJ. (1994). Am J Path 144: 675-682.
45. Watson CJ. (2001). J Mamm Gland Biol Neoplasia 6: 115-127.
46. Yamashita J, Ogawa M, Yamashita S, Nomura K, Kuramoto M, Saishoji T et al. (1994). Cancer Res 54: 1630-1633.
47. Yang J, Chatterjee-Kishore M, Staugaitis SM, Nguyen H, Schlessinger K, Levy DE et al. (2005). Cancer Res 65: 939-947.
48. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J et al. (1995). Science 269: 81-83.
49. Yuan ZL, Guan YJ, Chatterjee D, Chin YE. (2005). Science 307: 269-273.
50. Zhang YW, Wang LM, Jove R, Vande Woude GF. (2002). Oncogene 21: 217-226.